|
((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate
|
DB04280 |
|
|
2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone
|
DB04281 |
|
|
2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine
|
DB04288 |
|
|
Genz-10850
|
DB04289 |
|
|
Verubulin
|
DB05585 |
[Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.] |
|
Tretazicar
|
DB04253 |
[Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).] |
|
8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
|
DB04254 |
|
|
Praconase
|
DB05584 |
|
|
N-Carbamoyl-L-Aspartate
|
DB04252 |
|
|
Butyrylthiocholine
|
DB04250 |
[A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. [PubChem]] |
|
TRU-015
|
DB05580 |
|
|
7n-Methyl-8-Hydroguanosine-5'-Monophosphate
|
DB04259 |
|
|
Palmitoleic Acid
|
DB04257 |
|
|
Seocalcitol
|
DB04258 |
|
|
Inhibitor Bea388
|
DB04255 |
|
|
4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid
|
DB04256 |
|
|
Facinicline
|
DB05586 |
|
|
(10R)-10-Formyl-5,8,10-Trideazafolic Acid
|
DB04264 |
|
|
PRX-03140
|
DB05596 |
|
|
Farletuzumab
|
DB05595 |
[Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.] |
